Patient
Age
Gender
Primary cancer
Location
Pre OP VAS
Post OP 1 week
Post OP 1 month
Post OP 3 months
Post OP 6 Months
Analgesic reduction
Saliou filling score
1
54
M
Lung
L2
7
2
2
3
4
YES
10
2
39
F
Breast
D10
7
2
2
3
2
NO
12
3
57
M
Bladder
L4
9
5
3
3
4
YES
4
4
63
M
Bladder
D12
7
2
2
2
4
NO
14
5
62
F
Breast
D12
7
5
3
3
3
NO
9
6
69
M
Lung
L1
8
4
5
3
3
NO
8
7
60
M
Lung
L3
10
3
3
3
3
YES
12
8
34
F
Breast
L5
8
5
4
3
3
NO
10
9
53
M
Lung
L1
9
3
3
3
3
YES
5
10
49
F
Kidney
L2
7
5
3
2
2
NO
13
11
57
M
Breast
D12
6
4
2
2
3
YES
9
12
58
M
Lung
L1
8
3
2
2
2
NO
5
13
67
M
Lung
D11
10
3
4
4
4
NO
12
14
69
F
Breast
L3
7
2
2
3
4
YES
14
15
58
F
Kidney
L4
8
6
3
3
2
YES
12
16
62
M
Breast
D10
10
4
2
2
4
YES S
9
17
39
F
Lung
L2
8
2
2
2
2
NO
13
18
53
M
Melanoma
D8
9
3
4
2
2
YES
8
Mean
55.72
11 M/7 F
8.05
3.5
2.8
2.6
3.0
Table 2
Data of primary neoplasms
Table 3
Neoplastic vertebrae treated with radiofrequency ablation
Table 4
Inclusion and exclusion criteria
Inclusion criteria | Exclusion criteria |
---|---|
Unresecable tumors, according to Tokuhashi score | General contraindications for surgery (infection, allergy, bleeding diseases) |
Karnofsky score > 60 | Poor general condition (Karnofsky score < 60) |
Osteolytic lesion on neurimaging | Osteoblastic tumors on neurimaging |
VAS > 5 | VAS < 5 |
Intractable pain with chemotherapy, radiation therapy, or other treatments
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |